UpToDate vs OpenEvidence

UpToDate vs OpenEvidence: cost, sources and which one fits your day

Clinicians comparing UpToDate and OpenEvidence are usually deciding whether a long-standing paid reference still earns its subscription now that a free, well-funded answer engine exists. Both tools are good. They are also less interchangeable than the comparison implies, and the difference is not really price.

UpToDate gives you a curated recommendation: physician authors write and grade the topic, so what you read has been argued over before it reaches you. OpenEvidence gives you the literature, fast: you ask a question and it answers with citations you can open. This page compares them honestly on cost, sources and workflow, and it is candid about the one thing neither is designed to do, which is run the prescribing checks for the patient in front of you.

The Monograph Desk

Ready to check

Drug / scenario + Second drug / context

Press Run check to see the interaction, contraindication, and dosing decision-support card for this scenario.

Illustrative sample · decision-support only · verify against official sources

Interaction

Contraindication / allergy check

Dosing guidance (renal / hepatic)

Guideline-based alternatives

Sources

Illustrative sample · not real clinical advice · you verify and decide

Clinician-in-the-loop

Checked in · you review & sign

Decision support for licensed clinicians. Prescriber.io does not diagnose or prescribe and is not a substitute for professional clinical judgment.

See the comparison

Check · flag · suggest · you review and sign off

The short answer

UpToDate vs OpenEvidence, in brief

UpToDate is a paid, editorially written clinical reference (individual Pro subscriptions list around $579 a year) whose topic reviews are graded and updated by physician authors. OpenEvidence is free for NPI-verified US clinicians, funded by advertising, and answers a question by summarizing the peer-reviewed literature with citations. Pick UpToDate when you want a curated recommendation you can stand behind, OpenEvidence when you want fast, cited literature at no cost. Neither is built to run the interaction, contraindication and dose checks at the second you sign, which is the gap Prescriber.io fills.

Last updated July 2026

Side by side

UpToDate vs OpenEvidence vs Prescriber.io

All three are capable tools built for different moments. Here is where they differ, including where we are not the answer.

What matters	UpToDate	OpenEvidence	Prescriber.io
What it is	Editorially written clinical reference, topics authored and graded by physician editors	AI answer engine that summarizes peer-reviewed literature with citations	Point-of-care decision-support card for the prescription you are about to sign
Cost (individual, July 2026)	Paid subscription, individual UpToDate Pro lists around $579 per year	Free for verified clinicians, funded by advertising	From $39 per clinician per month, billed annually
Who can access it	Anyone who subscribes, plus institutional licences through hospitals and libraries	Clinicians who pass verification, NPI-based in the US	Licensed prescribers and clinical pharmacists
Where the content comes from	In-house physician authors and editors, with graded recommendations	Published literature, including content partnerships with major journals	Clinical pharmacology references, cited on each flag so you can confirm it
Answer format	A topic review you read, often several screens long	A written answer with linked citations	One card: interactions, contraindications, dose adjustments, alternatives
Drug interaction checking	Available through the integrated drug database (Lexidrug, formerly Lexicomp)	Answers the question if you ask it, as prose	Runs on every scenario you enter, without asking separately
Renal and hepatic dose adjustment	Present in the drug content, looked up per drug	Answered when you ask for it directly	Surfaced in the same card as the interaction check
Best suited for	Reading up on a condition and citing a graded recommendation	Getting a fast, cited literature answer at no cost	The prescribing moment, when several checks must happen at once

Competitor details reflect publicly published information as of July 2026. Products and prices change, so confirm current details with each vendor.

Which one, for whom

Pick the tool that matches the job

Choose UpToDate if

You want a recommendation that has been through editorial review and grading, and you want to cite it. Institutions often already pay for it, and residents in particular lean on its topic reviews as a way to learn a condition end to end rather than assemble it from papers.

Choose OpenEvidence if

You want the literature answer quickly, you want the citations in front of you, and you would rather not pay a subscription. Verification is straightforward for US clinicians with an NPI, and the ad-supported model means the cost question mostly disappears.

Add Prescriber.io if

Your problem is not finding the evidence but running the checks. Interactions, contraindications, renal and hepatic dosing and guideline alternatives arrive together in one card for the scenario you enter, so the checks happen even when the clinic is running late. You review each flag and sign.

Is OpenEvidence really free, or is there a catch?

It is genuinely free for clinicians who complete verification, which in the US means confirming your NPI. There is no paywall waiting behind the first few questions. The model is advertising: pharmaceutical and other healthcare advertisers pay to reach a verified clinical audience, which is how a tool that answers millions of clinical questions a month covers its costs.

The honest caveat is not a hidden fee, it is the incentive. An ad-supported tool sits in the same page as promotional content, and clinicians differ on how comfortable they are with that. If that bothers you, a paid reference removes the question entirely. If it does not, the free access is real and worth having.

Is UpToDate still worth paying for in 2026?

It depends on whether you value a graded, edited recommendation over a summary of the literature. UpToDate topics are written by named physician authors, reviewed, and given explicit strength-of-recommendation grades. When you are about to do something consequential and want a defensible position, that editorial layer is what you are paying for, and a literature summary is not the same thing.

Where the value gets harder to defend is speed. If your question is narrow and factual, reading a long topic review to extract one line is slow, and that is exactly the gap free answer engines moved into. Many clinicians have quietly settled on using both: the answer engine for quick questions, the paid reference when the decision is heavier. Also worth knowing before you renew: check whether your hospital or medical library already licenses it, because a great many US clinicians pay for a subscription they could access for free through their institution.

What neither tool does at the moment you prescribe

Both tools answer questions you ask. Neither watches the prescription you are about to sign and tells you, unprompted, that the patient is already on a drug that interacts with it, that their renal function makes the standard dose wrong, or that a documented allergy blocks the obvious choice. To get that from a reference or an answer engine you have to know to ask, four separate times, and prescribing errors mostly happen precisely when nobody thought to ask.

That is the job Prescriber.io is built for. You enter the drug or the scenario once and it checks for drug-drug interactions, flags contraindications and allergy blockers, surfaces renal and hepatic dose adjustments, and suggests guideline-based alternatives, together, with cited sources. It is decision-support, not autonomous prescribing. Every flag is a prompt for you, and you verify against official sources and sign.

See the check run on a scenario of your own

Interactions, contraindications, renal and hepatic dosing and guideline alternatives, in one card you review and sign off on.

Good questions

UpToDate vs OpenEvidence, answered

Neither is strictly better. OpenEvidence is faster and free, and gives you cited literature on demand. UpToDate gives you an edited, graded recommendation written by physician authors, which is what you want when the decision is consequential and you need to defend it. Many clinicians use both, for different questions.

Wolters Kluwer lists individual UpToDate Pro subscriptions at roughly $579 a year as of July 2026, with lower rates for residents and students and separately negotiated institutional pricing. Check the vendor for the current rate before you buy, and check whether your hospital or medical library already provides access.

In the United States, verification is based on your NPI, so practising clinicians with an NPI can register. The verification step is what keeps the tool clinician-facing rather than patient-facing, and it is why access can be free at the point of use.

Yes, and it is a sensible stack. Use OpenEvidence or UpToDate to answer the clinical question, and Prescriber.io at the point of prescribing to check interactions, contraindications and dosing in one card. They cover different moments in the same decision, and none of them replaces your clinical judgment.

Keep comparing

Run the prescribing checks in one card

Whichever reference you keep, the interaction, contraindication and dose checks still have to happen. Prescriber.io runs them together and cites its sources. You review, verify, and sign.

See pricing

Decision-support for licensed clinicians. Prescriber.io does not diagnose or prescribe autonomously and is not a substitute for professional clinical judgment. Always verify against official sources.